5/6/2020 12:33:07 PM - Rebounding toward its 52-week high since undercutting its 200 DMA line. Due to report Mar '20 quarterly earnings results on 5/07/20. Prior mid-day reports noted - "Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady."
5/1/2020 12:18:55 PM - Rebounded since undercutting its 200 DMA line. Prior mid-day reports noted - "Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady."
4/28/2020 12:17:07 PM - Rebounded since undercutting its 200 DMA line when last noted with caution in the 3/16/20 mid-day report - "Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady."
3/16/2020 12:34:10 PM - Gapped down today undercutting its 200 DMA line. Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady.
3/13/2020 12:19:05 PM - Gapped down on the prior session slumping near its 200 DMA line. Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady.
3/12/2020 12:26:13 PM - Gapped down slumping near its 200 DMA line. Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady.
3/6/2020 11:54:35 AM - Consolidating near its 50 DMA line. Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady.
11/23/2015 11:45:06 AM - Consolidating above its 200 DMA line, it faces resistance due to overhead supply up through the $340 level. Reported earnings +65% on +90% sales revenues for the Sep '15 quarter, a 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Prior downturn in FY '14 earnings is also a concern (A criteria).
8/12/2015 12:18:00 PM - Pulling back from all-time highs with volume-driven losses and today it undercut its 50 DMA line. The 8/07/15 mid-day report cautioned members - "Reported earnings +29% on +116% sales revenues for the Jun '15 quarter, an improvement after 2 consecutive quarterly earnings comparisons below the +25% minimum guideline (C criteria.
8/7/2015 12:35:52 PM - Pulled back from all-time highs with volume-driven losses testing support at prior highs and its 50 DMA line. Reported earnings +29% on +116% sales revenues for the Jun '15 quarter, an improvement after 2 consecutive quarterly earnings comparisons below the +25% minimum guideline (C criteria.
7/28/2015 12:16:21 PM - Perched at all-time highs following a gap up on the prior session when noted with caution in the mid-day report - "Reported earnings +23% on +59% sales revenues for the Mar '15 quarter, its 2nd consecutive quarterly earnings comparison below the +25% minimum guideline (C criteria)."
7/27/2015 12:13:56 PM - Gapped up today hitting new all-time highs. Reported earnings +23% on +59% sales revenues for the Mar '15 quarter, its 2nd consecutive quarterly earnings comparison below the +25% minimum guideline (C criteria).
3/16/2015 12:08:53 PM - Getting more extended from any sound base and hitting new all-time highs with today's 4th consecutive gain. Held its ground stubbornly and made steady progress since a gap up on 11/17/14 news it will be acquired by Actavis Plc (ACT). Reported earnings +61% on +13% sales revenues for the Dec '14 quarter, its 2nd consecutive quarterly earnings comparison well above the +25% minimum guideline (C criteria).
3/12/2015 11:46:52 AM - Extended from any sound base and perched at all-time highs. Held its ground stubbornly and made steady progress since a gap up on 11/17/14 news it will be acquired by Actavis Plc (ACT). Reported earnings +61% on +13% sales revenues for the Dec '14 quarter, its 2nd consecutive quarterly earnings comparison well above the +25% minimum guideline (C criteria).
2/5/2015 12:07:39 PM - Found support above its 50 DMA line while consolidating since a gap up on 11/17/14 news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +66% on +13% sales revenues for the Dec '14 quarter, its 2nd consecutive quarterly earnings comparison well above the +25% minimum guideline (C criteria).
11/24/2014 12:13:09 PM - Holding its ground since a gap up for a new 52-week high on 11/17/14 news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but prior quarterly earnings comparisons were just below the +25% minimum guideline (C criteria).
11/21/2014 12:17:57 PM - Gapped up for a new 52-week high on 11/17/14 news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but prior quarterly earnings comparisons were just below the +25% minimum guideline (C criteria).
11/18/2014 12:06:16 PM - Gapped up for a new 52-week high on 11/17/14 news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but prior quarterly earnings comparisons were just below the +25% minimum guideline (C criteria).
11/17/2014 12:18:52 PM - Gapped up for a new 52-week high on news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but prior quarterly earnings comparisons were just below the +25% minimum guideline (C criteria).
11/12/2014 12:16:29 PM - Holding its ground stubbornly at its 52-week high following a recent streak of 8 consecutive gains. Found prompt support after briefly undercutting prior highs in the $174 area and testing support at its 50 DMA line while recently enduring distributional pressure. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but fundamental concerns remain. Prior mid-day reports cautioned members - "Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
11/6/2014 12:11:41 PM - Hitting a new 52-week high with today's 8th consecutive gain. Found prompt support after briefly undercutting prior highs in the $174 area and testing support at its 50 DMA line while recently enduring distributional pressure. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but fundamental concerns remain. Prior mid-day reports cautioned members - "Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
10/27/2014 11:57:21 AM - Found prompt support after briefly undercutting prior highs in the $174 area and testing support at its 50 DMA line while recently enduring distributional pressure. Prior mid-day reports cautioned members - "Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
10/15/2014 12:02:54 PM - Undercut prior highs in the $174 area today and tested support at its 50 DMA line. Encountering distributional pressure while retreating from its 52-week high. Prior mid-day reports cautioned members - "Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
10/14/2014 12:03:14 PM - Finding support near prior highs in the $174 area with today's gain after encountering distributional pressure and retreating from its 52-week high. Prior mid-day reports cautioned members - "Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
10/9/2014 11:52:26 AM - Found support recently at its 50 DMA line and rallying to new 52-week highs with today's 3rd consecutive gain on above average volume. Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Prior mid-day reports cautioned members - "Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
10/8/2014 12:13:22 PM - Found support at its 50 DMA line and rallied to new 52-week highs with gains on above average volume since last noted with caution in the 9/23/14 mid-day report. Held its ground following a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Prior mid-day reports cautioned members - "Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
9/23/2014 12:09:36 PM - Found support at its 50 DMA line with a gain today on higher volume. Consolidating in a tight range since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Prior mid-day reports cautioned members - "Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
8/5/2014 11:50:31 AM - Slumped below its 50 DMA line with a streak of 4 consecutive losses. Consolidating in a tight range since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Prior mid-day reports cautioned members - "Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
7/31/2014 11:39:37 AM - Gapped down today retreating from its 52-week high. Consolidated in a tight range since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Prior mid-day reports cautioned members - "Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
6/2/2014 12:05:56 PM - Touching a new 52-week high today. Consolidating since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +20% on +13% sales revenues for the Mar '14 quarter. Prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
5/28/2014 12:15:38 PM - Today's volume-driven loss has it slumping to new lows since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +20% on +13% sales revenues for the Mar '14 quarter. Prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
5/13/2014 12:24:34 PM - Reported earnings +20% on +13% sales revenues for the Mar '14 quarter. Consolidating in a tight range near its high since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). While rebounding from below its 50 DMA line prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/24/2014 12:03:16 PM - Holding its ground after a considerable gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Perched at its 52-week high after 8 consecutive volume-driven gains. While rebounding from below its 50 DMA line prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/23/2014 12:26:46 PM - Holding its ground today after a considerable gap up gain on the prior session following an unsolicited bid from Valeant Pharmaceuticals (VRX). Perched at its 52-week high after 7 consecutive volume-driven gains. While rebounding from below its 50 DMA line prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/22/2014 12:10:04 PM - Received an unsolicited bid from Valeant Pharmaceuticals (VRX) and gapped up today for a considerable gain and another new 52-week high, on track for its 7th consecutive volume-driven gain. While rebounding from below its 50 DMA line prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/21/2014 11:54:31 AM - Hitting another new 52-week high with today's 6th consecutive volume-driven gain. While rebounding from below its 50 DMA line prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/17/2014 12:06:34 PM - Hitting a new 52-week high with today's 5th consecutive volume-driven gain. While rebounding from below its 50 DMA line prior mid-day reports cautioned members - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/16/2014 12:03:57 PM - Rebounded above its 50 DMA line and it is approaching its 52-week high with today's 4th consecutive volume-driven gain. Prior mid-day reports cautioned - "Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
4/15/2014 12:00:51 PM - Rebounding above its 50 DMA line with today's 3rd consecutive volume-driven gain. Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Prior mid-day reports cautioned - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
4/14/2014 12:07:50 PM - Rebounding toward its 50 DMA line which may act as resistance. Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Prior mid-day reports cautioned - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
4/8/2014 12:00:57 PM - Slumping further below its 50 DMA line with damaging volume-driven losses. Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Prior mid-day reports cautioned - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
3/27/2014 12:18:22 PM - Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Slumping below its 50 DMA line with damaging volume-driven losses. Prior mid-day reports cautioned - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
3/26/2014 12:19:41 PM - Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Retreated to its 50 DMA line abruptly after wedging to new 52-week highs with gains lacking great volume conviction. Prior mid-day reports cautioned - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
3/21/2014 11:53:12 AM - Quarterly reports through Dec '13 showed sub par earnings increases while its annual earnings growth has been steady. Recently wedged to new 52-weeks with gains lacking great volume conviction. Last noted in the 5/02/12 mid-day report with caution - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
5/2/2012 12:05:28 PM - Gapped down today and violated its 50 DMA line following another quarterly report with sub par sales revenues and earnings increases. The 3/08/12 mid-day report noted - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
3/8/2012 11:53:59 AM - Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report.
10/27/2011 11:47:20 AM - Gapped down on the prior session, abruptly slumping below prior chart highs after reporting earnings +18% on +10% sales revenues for the quarter ended September 30, 2011 versus the year ago period. The 10/21/11 mid-day report noted the pending earnings news as it wedged to new 52-week highs without great volume conviction, and added - "Prior quarterly comparisons have been below the +25% guideline. Rebounded impressively after undercutting its 200 DMA line during its latest consolidation."
10/26/2011 12:15:17 PM - Gapped down today, abruptly slumping below prior chart highs after reporting earnings +18% on +10% sales revenues for the quarter ended September 30, 2011 versus the year ago period. The 10/21/11 mid-day report noted the pending earnings news as it wedged to new 52-week highs without great volume conviction, and added - "Prior quarterly comparisons have been below the +25% guideline. Rebounded impressively after undercutting its 200 DMA line during its latest consolidation."
10/21/2011 12:44:24 PM - Gapped up today and hit a new 52-week high. Reported earnings +13% on +14% sales revenues for the quarter ended June 30, 2011 versus the year ago period, and prior quarterly comparisons have been below the +25% guideline. Due to report earnings for the latest quarter on Wednesday, October 26th. Rebounded impressively after undercutting its 200 DMA line during its latest consolidation.
10/5/2011 12:18:54 PM - Reported earnings +13% on +14% sales revenues for the quarter ended June 30, 2011 versus the year ago period. Rebounded in recent weeks to challenge its 52-week high after undercutting its 200 DMA line during its consolidation since noted in the 6/22/11 mid-day report - "It has shown steady annual earnings growth, but quarterly earnings and sales increases have repeatedly been reported below guidelines through the Mar '11 quarter."
9/22/2011 12:33:40 PM - Reported earnings +13% on +14% sales revenues for the quarter ended June 30, 2011 versus the year ago period. Rebounded in recent weeks to challenge its 52-week high after undercutting its 200 DMA line during its consolidation since noted in the 6/22/11 mid-day report - "It has shown steady annual earnings growth, but quarterly earnings and sales increases have repeatedly been reported below guidelines through the Mar '11 quarter."
9/8/2011 12:17:16 PM - Reported earnings +13% on +14% sales revenues for the quarter ended June 30, 2011 versus the year ago period. Rebounding in recent weeks after undercutting its 200 DMA line during its consolidation since last noted in the 6/22/11 mid-day report - "It has shown steady annual earnings growth, but quarterly earnings and sales increases have repeatedly been reported below guidelines through the Mar '11 quarter."
6/22/2011 12:06:07 PM - Found support near its 50 DMA line last week during its quiet consolidation since last noted in the 5/19/11 mid-day report - "Hit new 52-week and all-time highs with a solid gain on the prior session with above average volume, getting more extended from any sound base pattern. It has shown steady annual earnings growth, but quarterly earnings and sales increases have repeatedly been reported below guidelines through the Mar '11 quarter."
5/19/2011 12:22:02 PM - Hit new 52-week and all-time highs with a solid gain on the prior session with above average volume, getting more extended from any sound base pattern. It has shown steady annual earnings growth, but quarterly earnings and sales increases have repeatedly been reported below guidelines through the Mar '11 quarter.
11/3/2010 12:20:59 PM - Gapped down today from its 52-week high. It continued rallying after a "breakaway gap" on 10/18/10 allowed it to rise above multi-year resistance in the $69-70 area. It has shown steady annual earnings growth, but quarterly earnings and sales increases have repeatedly been reported below guidelines through the Sep '10 quarter.
1/18/2008 12:28:15 PM - Bounced at its 200 DMA line recently and rebounded quickly above the 50 DMA line to challenge prior resistance in the $69 area. Steady annual earnings growth, but the 4 latest quarterly earnings increases have been borderline or below guidelines.
1/17/2008 12:51:36 PM - Bounced at its 200 DMA line last week and rebounded quickly above the 50 DMA line to challenge prior resistance in the $69 area. Steady annual earnings growth, but the 4 latest quarterly earnings increases have been borderline or below guidelines.
1/16/2008 12:34:07 PM - Bounced at its 200 DMA line last week and rebounded quickly above the 50 DMA line to challenge prior resistance in the $69 area. Steady annual earnings growth, but the 4 latest quarterly earnings increases have been borderline or below guidelines.
1/10/2008 12:51:06 PM - Bounnced at its 200 DMA line and rebounded quickly above the 50 DMA line to challenge prior resistance in the $69 area. Steady annual earnings growth, but the 4 latest quarterly earnings increases have been borderline or below guidelines.
8/7/2007 12:23:12 PM - No base and "C" below guidelines.
3/13/2006 12:29:08 PM - Base somewhat questionable and "C" below guidelines.
3/9/2006 12:28:18 PM - Base somewhat questionable and "C" questionable.
1/10/2006 12:28:01 PM - Base somewhat questionable.
12/21/2005 12:24:35 PM - Base somewhat questionable.
12/8/2005 12:22:26 PM - Too ET from a sound base of support at this point to be considered buyable under the guidelines.
12/6/2005 12:28:41 PM - C and base somewhat questionable.
12/5/2005 12:20:35 PM - C and base somewhat questionable.
11/23/2005 12:38:40 PM - C and base somewhat questionable.
11/21/2005 12:25:05 PM - C and base somewhat questionable.
11/18/2005 12:24:04 PM - C and base somewhat questionable.